Vulnerability versus resilience to prenatal stress in male and female rats; Implications from gene expression profiles in the hippocampus and frontal cortex

European Neuropsychopharmacology

Volumn 23, Issue 10, 2013, Pages 1226-1246

  Van den Hove, D L A ^a,b   Kenis, G ^a   Brass, A ^c   Opstelten, R ^a   Rutten, B P F ^a   Bruschettini, M ^a   Blanco, C E ^d   Lesch, K P ^a,b   Steinbusch, H W M ^a   Prickaerts, J ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Anxiety; Depression; Epigenetics; Microarray; Prenatal stress; Resilience

Indexed keywords

ANTIDEPRESSANT AGENT; CORTICOSTERONE; CYCLIC NUCLEOTIDE; GLYCOGEN SYNTHASE KINASE 3; HISTONE DEACETYLASE INHIBITOR; INSULIN; MITOGEN ACTIVATED PROTEIN KINASE; MOOD STABILIZER; NEUROTROPHIC FACTOR; PHOSPHODIESTERASE; PHOSPHODIESTERASE INHIBITOR;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DEPRESSION; DISEASE PREDISPOSITION; DRUG MECHANISM; FEMALE; FRONTAL CORTEX; GABAERGIC TRANSMISSION; GENE EXPRESSION; GENE EXPRESSION PROFILING; HIPPOCAMPUS; IMMOBILIZATION STRESS; MALE; MOUSE; NEUROTRANSMISSION; NONHUMAN; PRENATAL STRESS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANXIETY; DEPRESSION; EPIGENETICS; MICROARRAY; PRENATAL STRESS; RESILIENCE;

ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; CORTICOSTERONE; DEPRESSION; DISEASE SUSCEPTIBILITY; EPIGENESIS, GENETIC; FEMALE; FRONTAL LOBE; GENE EXPRESSION REGULATION; HIPPOCAMPUS; MALE; NERVE TISSUE PROTEINS; NEURONS; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL EXPOSURE DELAYED EFFECTS; RATS; RATS, SPRAGUE-DAWLEY; RESTRAINT, PHYSICAL; SEX CHARACTERISTICS; SIGNAL TRANSDUCTION; STRESS, PHYSIOLOGICAL; STRESS, PSYCHOLOGICAL;

EID: 84884289212     PISSN: 0924977X     EISSN: 18737862     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2012.09.011     Document Type: Article

References (88)

1. Aberg N.D., Brywe K.G., Isgaard J. Aspects of growth hormone and insulin-like growth factor-I related to neuroprotection, regeneration, and functional plasticity in the adult brain. Sci. World J. 2006, 6:53-80. PMID:16432628.
2. Alonso S.J., Castellano M.A., Quintero M., Navarro E. Action of antidepressant drugs on maternal stress-induced hypoactivity in female rats. Methods Find. Exp. Clin. Pharmacol. 1999, 21:291-295.
3. Alttoa A., Koiv K., Hinsley T.A., Brass A., Harro J. Differential gene expression in a rat model of depression based on persistent differences in exploratory activity. Eur. Neuropsychopharmacol. 2010, 20:288-300.
4. Bale T.L. Sex differences in prenatal epigenetic programming of stress pathways. Stress 2011, 14:348-356.
5. Bender A.T., Beavo J.A. Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use. Pharmacol. Rev. 2006, 58:488-520.
6. Blehar M.C. Gender differences in risk factors for mood and anxiety disorders: implications for clinical treatment research. Psychopharmacol. Bull. 1995, 31:687-691.
7. Bolstad B.M., Irizarry R.A., Astrand M., Speed T.P. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 2003, 19(2):185-193. PMID: 12538238.
8. Bonow R.H., Aid S., Zhang Y., Becker K.G., Bosetti F. The brain expression of genes involved in inflammatory response, the ribosome, and learning and memory is altered by centrally injected lipopolysaccharide in mice. Pharmacogenomics J. 2009, 9:116-126.
9. Brown E.S., Varghese F.P., McEwen B.S. Association of depression with medical illness: does cortisol play a role?. Biol. Psychiatry 2004, 55:1-9.
10. Chapman R.H., Stern J.M. Maternal stress and pituitary-adrenal manipulations during pregnancy in rats: effects on morphology and sexual behavior of male offspring. J. Comp. Physiol. Psychol. 1978, 92:1074-1083.
11. Covington H.E., Vialou V.F., Laplant Q., Ohnishi Y.N., Nestler E.J. Hippocampal-dependent antidepressant-like activity of histone deacetylase inhibition. Neurosci. Lett 2011.
12. Daimon M., Sato H., Oizumi T., Toriyama S., Saito T., Karasawa S., Jimbu Y., Wada K., Kameda W., Susa S., Yamaguchi H., Emi M., Muramatsu M., Kubota I., Kawata S., Kato T. Association of the PIK3C2G gene polymorphisms with type 2 DM in a Japanese population. Biochem. Biophys. Res. Commun. 2008, 365(3):466-471.. Epub 2007 November 6. PMID:17991425.
13. Dalla C., Antoniou K., Drossopoulou G., Xagoraris M., Kokras N., Sfikakis A., Papadopoulou-Daifoti Z. Chronic mild stress impact: are females more vulnerable?. Neuroscience 2005, 135:703-714.
14. Darnaudery M., Maccari S. Epigenetic programming of the stress response in male and female rats by prenatal restraint stress. Brain Res. Rev. 2007.
15. De Kloet E.R., Oitzl M.S. Who cares for a stressed brain? The mother, the kid or both?. Neurobiol. Aging 2003, 24(Suppl. 1):S61-S65. (discussion S67-S68).
16. Devaskar S.U., Giddings S.J., Rajakumar P.A., Carnaghi L.R., Menon R.K., Zahm D.S. Insulin gene expression and insulin synthesis in mammalian neuronal cells. J. Biol. Chem. 1994, 269:8445-8454.
17. Dong C., Wong M.L., Licinio J. Sequence variations of ABCB1, SLC6A2, SLC6A3, SLC6A4, CREB1, CRHR1 and NTRK2: association with major depression and antidepressant response in Mexican-Americans. Mol. Psychiatry 2009, 14:1105-1118.
18. Dugovic C., Maccari S., Weibel L., Turek F.W., Van Reeth O. High corticosterone levels in prenatally stressed rats predict persistent paradoxical sleep alterations. J. Neurosci. 1999, 19:8656-8664.
19. Dunning M.J., Smith M.L., Ritchie M.E., Tavaré S. Beadarray: R classes and methods for Illumina bead-based data. Bioinformatics 2007, 23(16):2183-2184.. Epub 2007 June 22. PMID: 17586828.
20. Duman R.S., Monteggia L.M. A neurotrophic model for stress-related mood disorders. Biol. Psychiatry 2006, 59:1116-1127.
21. Emamian E.S., Hall D., Birnbaum M.J., Karayiorgou M., Gogos J.A. Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia. Nat. Genet. 2004, 36:131-137.
22. Gould T.D., Einat H., Bhat R., Manji H.K. AR-A014418, a selective GSK-3 inhibitor, produces antidepressant-like effects in the forced swim test. Int. J. Neuropsychopharmacol. 2004, 7:387-390.
23. Gould T.D., Zarate C.A., Manji H.K. Glycogen synthase kinase-3: a target for novel bipolar disorder treatments. J. Clin. Psychiatry 2004, 65:10-21.
24. Grayson D.R., Kundakovic M., Sharma R.P. Is there a future for histone deacetylase inhibitors in the pharmacotherapy of psychiatric disorders?. Mol. Pharmacol. 2010, 77:126-135.
25. Grimes C.A., Jope R.S. The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling. Prog. Neurobiol. 2001, 65:391-426.
26. Gronli J., Murison R., Fiske E., Bjorvatn B., Sorensen E., Portas C.M., Ursin R. Effects of chronic mild stress on sexual behavior, locomotor activity and consumption of sucrose and saccharine solutions. Physiol. Behav. 2005, 84:571-577.
27. Halene T.B., Siegel S.J. PDE inhibitors in psychiatry - future options for dementia, depression and schizophrenia?. Drug Disc. Today 2007, 12:870-878.
28. Hashimoto K. Emerging role of glutamate in the pathophysiology of major depressive disorder. Brain Res. Rev. 2009, 61:105-123.
29. Hashimoto K. Emerging role of glutamate in the pathophysiology of major depressive disorder. Brain Res. Rev. 2009, 61:105-123.
30. Huang da W., Sherman B.T., Lempicki R.A Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 2009, 4:44-57.
31. Huizink A.C., Mulder E.J., Buitelaar J.K. Prenatal stress and risk for psychopathology: specific effects or induction of general susceptibility?. Psychol. Bull. 2004, 130:115-142.
32. Hur E.M., Zhou F.Q. GSK3 signalling in neural development. Nat. Rev. Neurosci. 2010, 11:539-551.
33. Kaidanovich-Beilin O., Milman A., Weizman A., Pick C.G., Eldar-Finkelman H. Rapid antidepressive-like activity of specific glycogen synthase kinase-3 inhibitor and its effect on beta-catenin in mouse hippocampus. Biol. Psychiatry 2004, 55:781-784.
34. Kalueff A.V., Nutt D.J. Role of GABA in anxiety and depression. Depress. Anxiety 2007, 24:495-517.
35. Kobayashi M., Masaki T., Hori K., Masuo Y., Miyamoto M., Tsubokawa H., Noguchi H., Nomura M., Takamatsu K. Hippocalcin-deficient mice display a defect in cAMP response element-binding protein activation associated with impaired spatial and associative memory. Neuroscience 2005, 133:471-484.
36. Krishnan V., Nestler E.J. The molecular neurobiology of depression. Nature 2008, 455:894-902.
37. Laloux C., Mairesse J., Van Camp G., Giovine A., Branchi I., Bouret S., Morley-Fletcher S., Bergonzelli G., Malagodi M., Gradini R., Nicoletti F., Darnaudery M., Maccari S. Anxiety-like behaviour and associated neurochemical and endocrinological alterations in male pups exposed to prenatal stress. Psychoneuroendocrinology 2012.
38. Li X., Jope R.S. Is glycogen synthase kinase-3 a central modulator in mood regulation?. Neuropsychopharmacology 2010, 35:2143-2154.
39. Lustman P.J., Clouse R.E. Depression in diabetic patients: the relationship between mood and glycemic control. J. Diabetes Complications 2005, 19:113-122.
40. Matrisciano F., Tueting P., Maccari S., Nicoletti F., Guidotti A. Pharmacological activation of group-II metabotropic glutamate receptors corrects a schizophrenia-like phenotype induced by prenatal stress in mice. Neuropsychopharmacology 2012, 37(4):929-938. Epub 2011 November 16. PMID:22089319. 10.1038/npp.2011.274.
41. McClung C.A., Nestler E.J. Neuroplasticity mediated by altered gene expression. Neuropsychopharmacology 2008, 33:3-17.
42. McEwen B.S., Magarinos A.M., Reagan L.P. Studies of hormone action in the hippocampal formation: possible relevance to depression and diabetes. J. Psychosom. Res. 2002, 53:883-890.
43. Mill J., Petronis A. Molecular studies of major depressive disorder: the epigenetic perspective. Mol. Psychiatry 2007, 12:799-814.
44. Morley-Fletcher S., Darnaudery M., Koehl M., Casolini P., Van Reeth O., Maccari S. Prenatal stress in rats predicts immobility behavior in the forced swim test. Effects of a chronic treatment with tianeptine. Brain Res. 2003, 989:246-251.
45. Morley-Fletcher S., Rea M., Maccari S., Laviola G. Environmental enrichment during adolescence reverses the effects of prenatal stress on play behaviour and HPA axis reactivity in rats. Eur. J. Neurosci. 2003, 18:3367-3374.
46. Morley-Fletcher S., Darnaudery M., Mocaer E., Froger N., Lanfumey L., Laviola G., Casolini P., Zuena A.R., Marzano L., Hamon M., Maccari S. Chronic treatment with imipramine reverses immobility behaviour, hippocampal corticosteroid receptors and cortical 5-HT(1A) receptor mRNA in prenatally stressed rats. Neuropharmacology 2004, 47:841-847.
47. Morley-Fletcher S., Mairesse J., Soumier A., Banasr M., Fagioli F., Gabriel C., Mocaer E., Daszuta A., McEwen B., Nicoletti F., Maccari S. Chronic agomelatine treatment corrects behavioral, cellular, and biochemical abnormalities induced by prenatal stress in rats. Psychopharmacology (Berl) 2011, 217:301-313.
48. Mueller B.R., Bale T.L. Sex-specific programming of offspring emotionality after stress early in pregnancy. J. Neurosci. 2008, 28:9055-9065.
49. Noguchi H., Kobayashi M., Miwa N., Takamatsu K. Lack of hippocalcin causes impairment in Ras/extracellular signal-regulated kinase cascade via a Raf-mediated activation process. J. Neurosci. Res. 2007, 85:837-844.
50. Ott A., Stolk R.P., van Harskamp F., Pols H.A., Hofman A., Breteler M.M. Diabetes mellitus and the risk of dementia: the Rotterdam study. Neurology 1999, 53:1937-1942.
51. Owen D., Matthews S.G. Glucocorticoids and sex-dependent development of brain glucocorticoid and mineralocorticoid receptors. Endocrinology 2003, 144:2775-2784.
52. Pilc A., Chaki S., Nowak G., Witkin J.M. Mood disorders: regulation by metabotropic glutamate receptors. Biochem. Pharmacol. 2008, 75:997-1006.
53. Pittenger C., Sanacora G., Krystal J.H. The NMDA receptor as a therapeutic target in major depressive disorder. CNS Neurol. Disord. Drug Targets 2007, 6:101-115.
54. Poltyrev T., Gorodetsky E., Bejar C., Schorer-Apelbaum D., Weinstock M. Effect of chronic treatment with ladostigil (TV-3326) on anxiogenic and depressive-like behaviour and on activity of the hypothalamic-pituitary-adrenal axis in male and female prenatally stressed rats. Psychopharmacology (Berl) 2005, 181:118-125.
55. Poltyrev T., Weinstock M. Gender difference in the prevention of hyperanxiety in adult prenatally stressed rats by chronic treatment with amitriptyline. Psychopharmacology (Berl) 2004, 171:270-276.
56. Porsolt R.D., Anton G., Blavet N., Jalfre M. Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur. J. Pharmacol. 1978, 47:379-391.
57. Price R.B., Shungu D.C., Mao X., Nestadt P., Kelly C., Collins K.A., Murrough J.W., Charney D.S., Mathew S.J. Amino acid neurotransmitters assessed by proton magnetic resonance spectroscopy: relationship to treatment resistance in major depressive disorder. Biol. Psychiatry 2009, 65:792-800.
58. Prickaerts J., Raaijmakers W., Blokland A. Effects of myocardial infarction and captopril therapy on anxiety-related behaviors in the rat. Physiol. Behav. 1996, 60:43-50.
59. Reagan L.P. Insulin signaling effects on memory and mood. Curr. Opin. Pharmacol. 2007, 7:633-637.
60. Reneerkens O.A., Rutten K., Steinbusch H.W., Blokland A., Prickaerts J. Selective phosphodiesterase inhibitors: a promising target for cognition enhancement. Psychopharmacology (Berl) 2009, 202:419-443.
61. Renthal W., Nestler E.J. Chromatin regulation in drug addiction and depression. Dialogues Clin. Neurosci. 2009, 11:257-268.
62. Robertson S.D., Matthies H.J., Owens W.A., Sathananthan V., Christianson N.S., Kennedy J.P., Lindsley C.W., Daws L.C., Galli A. Insulin reveals Akt signaling as a novel regulator of norepinephrine transporter trafficking and norepinephrine homeostasis. J. Neurosci. 2010, 30:11305-11316.
63. Salas T.R., Reddy S.A., Clifford J.L., Davis R.J., Kikuchi A., Lippman S.M., Menter D.G. Alleviating the suppression of glycogen synthase kinase-3beta by Akt leads to the phosphorylation of cAMP-response element-binding protein and its transactivation in intact cell nuclei. J. Biol. Chem. 2003, 278:41338-41346.
64. Sanguinetti G., Lawrence N.D., Rattray M. Probabilistic inference of transcription factor concentrations and gene-specific regulatory activities. Bioinformatics 2006, 22(22):2775-2781.. Epub 2006 September 11. PMID:16966362.
65. Schmidt H.D., Duman R.S. Peripheral BDNF produces antidepressant-like effects in cellular and behavioral models. Neuropsychopharmacology 2011, 35:2378-2391.
66. Sheline Y.I., Gado M.H., Kraemer H.C. Untreated depression and hippocampal volume loss. Am J. Psychiatry 2003, 160:1516-1518.
67. Shepherd J.K., Grewal S.S., Fletcher A., Bill D.J., Dourish C.T. Behavioural and pharmacological characterisation of the elevated "zero-maze" as an animal model of anxiety. Psychopharmacology (Berl) 1994, 116:56-64.
68. Smirnov A., Entelis N., Martin R.P., Tarassov I. Biological significance of 5S rRNA import into human mitochondria: role of ribosomal protein MRP-L18. Genes Dev. 2011, 25(12):1289-1305. PMID: 21685364. 10.1101/gad.624711.
69. Strackx E., Van den Hove D.L., Prickaerts J., Zimmermann L., Steinbusch H.W., Blanco C.E., Gavilanes A.W., Vles J.S. Fetal asphyctic preconditioning protects against perinatal asphyxia-induced behavioral consequences in adulthood. Behav. Brain Res. 2009, 208:343-351.
70. Sulon J., Demey-Ponsart L., Beauduin P., Sodoyez J.C. Radioimmunoassay of corticosterone, cortisol and cortisone: their application to human cord and maternal plasma. J. Steroid Biochem. 1978, 9:671-676.
71. Tanis K.Q., Duman R.S. Intracellular signaling pathways pave roads to recovery for mood disorders. Ann. Med. 2007, 39:531-544.
72. Tanis K.Q., Newton S.S., Duman R.S. Targeting neurotrophic/growth factor expression and signaling for antidepressant drug development. CNS Neurol. Disord. Drug Targets 2007, 6:151-160.
73. Taylor W.D., Kuchibhatla M., Payne M.E., Macfall J.R., Sheline Y.I., Krishnan K.R., Doraiswamy P.M. Frontal white matter anisotropy and antidepressant remission in late-life depression. PLoS One 2008, 3:e3267.
74. Tsankova N., Renthal W., Kumar A., Nestler E.J. Epigenetic regulation in psychiatric disorders. Nat. Rev. Neurosci. 2007, 8:355-367.
75. Van den Bergh B.R.H., Mulder E.J.H., Mennes M., Glover V. Antenatal maternal anxiety and stress and the neurobehavioural development of the fetus and child: links and possible mechanisms. A review. Neurosci. Biobehav. Rev. 2005, 29:237-258.
76. Van den Hove D.L., Blanco C.E., Aendekerk B., Desbonnet L., Bruschettini M., Steinbusch H.P., Prickaerts J., Steinbusch H.W. Prenatal restraint stress and long-term affective consequences. Dev. Neurosci. 2005, 27:313-320.
77. Van den Hove D.L., Kenis G., Steinbusch H.W., Blanco C.E., Prickaerts J. Maternal stress-induced reduction in birth weight as a marker for adult affective state. Front Biosci. (Elite ed.) 2010, 2:43-46.
78. Wada A. Lithium and neuropsychiatric therapeutics: neuroplasticity via glycogen synthase kinase-3beta, beta-catenin, and neurotrophin cascades. J. Pharmacol. Sci. 2009, 110:14-28.
79. Ward I.L., Weisz J. Differential effects of maternal stress on circulating levels of corticosterone, progesterone, and testosterone in male and female rat fetuses and their mothers. Endocrinology 1984, 114:1635-1644.
80. Waterland R.A., Jirtle R.L. Early nutrition, epigenetic changes at transposons and imprinted genes, and enhanced susceptibility to adult chronic diseases. Nutrition 2004, 20:63-68.
81. Weinstock M. Alterations induced by gestational stress in brain morphology and behaviour of the offspring. Prog. Neurobiol. 2001, 65:427-451.
82. Willner P., Muscat R., Papp M. Chronic mild stress-induced anhedonia: a realistic animal model of depression. Neurosci. Biobehav. Rev. 1992, 16:525-534.
83. Wong M.L., Whelan F., Deloukas P., Whittaker P., Delgado M., Cantor R.M., McCann S.M., Licinio J. Phosphodiesterase genes are associated with susceptibility to major depression and antidepressant treatment response. Proc. Natl. Acad. Sci. USA 2006, 103:15124-15129.
84. Yang P.C., Yang C.H., Huang C.C., Hsu K.S. Phosphatidylinositol 3-kinase activation is required for stress protocol-induced modification of hippocampal synaptic plasticity. J. Biol. Chem. 2008, 283(5):2631-2643. Epub 2007 December 5. PMID:18057005.
85. Zhang H.T., Huang Y., Masood A., Stolinski L.R., Li Y., Zhang L., Dlaboga D., Jin S.L., Conti M., O'Donnell J.M. Anxiogenic-like behavioral phenotype of mice deficient in phosphodiesterase 4B (PDE4B). Neuropsychopharmacology 2008, 33:1611-1623.
86. Zhang L., Rubinow D.R., Ma W., Marks J.M., Feldman A.N., Barker J.L., Tathan T.A. GABA receptor subunit mRNA expression in brain of conflict, yoked control and control rats. Brain Res. Mol. Brain Res. 1998, 58:16-26.
87. Zhao W.Q., Alkon D.L. Role of insulin and insulin receptor in learning and memory. Mol. Cell. Endocrinol. 2001, 177:125-134.
88. Zuena A.R., Mairesse J., Casolini P., Cinque C., Alema G.S., Morley-Fletcher S., Chiodi V., Spagnoli L.G., Gradini R., Catalani A., Nicoletti F., Maccari S. Prenatal restraint stress generates two distinct behavioral and neurochemical profiles in male and female rats. PLoS One 2008, 3:e2170.